НовостиBenzingaTruist Securities Reiterates Buy on BeOne Medicines, Raises Price Target to $448 Truist Securities Reiterates Buy on BeOne Medicines, Raises Price Target to $448 Benzinga 2026.11.06 17:51 (GMT+0) Открыть на Benzinga Другие новости